Epicor Inc. of Sunnyvale received $20 million in a third round of venture capital financing. Menlo Park's Sprout Group served as lead investor.
Epicor makes a device that treats heart muscles, reducing the risk of heartbeat irregularities known as aortal fibrillation. The condition causes blood clots.
The Sprout Group, a...
Epicor makes a device that treats heart muscles, reducing the risk of heartbeat irregularities known as aortal fibrillation. The condition causes blood clots.
The Sprout Group, a...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In